CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENTConfidential Settlement and License Agreement • March 29th, 2016 • Spherix Inc • Patent owners & lessors • Delaware
This SETTLEMENT AND LICENSE AGREEMENT (the “Agreement”) is by and between NNPT, LLC, a Texas limited liability corporation, and SPHERIX INCORPORATED, as Delaware corporation (collectively “Licensor”), and HUAWEI TECHNOLOGIES CO., LTD.; a Chinese company with major business address at Huawei Industrial Base, Bantian, Longgang District, Shenzhen 518129 P.R. China (hereinafter referred as “Huawei”) on behalf of itself and all Licensees (each a “Party” and both collectively “Parties”). This Agreement is effective as of September 16, 2015 (“Effective Date”).
CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENTConfidential Settlement and License Agreement • August 8th, 2018 • Horizon Pharma PLC • Pharmaceutical preparations • New Jersey
Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc. respectfully move to withdraw as Appellees and named parties from this appeal. Appellant Horizon Therapeutics, LLC consents to the withdrawal. Appellees’ withdrawal is appropriate because the parties have reached a confidential settlement agreement.The parties have agreed to bear their own costs.
Confidential Settlement and License AgreementConfidential Settlement and License Agreement • March 10th, 2016 • Vringo Inc • Patent owners & lessors • New York
This Confidential Settlement and License Agreement (“Agreement”) is effective as of December 3, 2015 (“Effective Date”) between Vringo, Inc, a corporation organized under the laws of Delaware having its principal place of business at 780 Third Avenue, 12th Floor, New York, New York 10017 for itself and on behalf of its Affiliates (individual and together “Vringo”) and ZTE Corporation, a corporation organized under the laws of China and having its principal place of business at ZTE Plaza, Keji Road South, Hi-Tech Industrial Park, Nanshan District, Shenzhen, P.R. China, for itself and on behalf of its Affiliates (individually and together “ZTE”).
CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENTConfidential Settlement and License Agreement • May 11th, 2018 • Progenics Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
This Confidential Settlement And License Agreement (the “Settlement Agreement”) is made effective as of May 10, 2018 (the “Effective Date”) by and among Valeant Pharmaceuticals International, inc., a Canadian corporation with its United States headquarters at 400 Somerset Corporate Boulevard, Bridgewater, New Jersey 08807 (“Valeant”), SALIX PHARMACEUTICALS, INC., a California corporation with its principal place of business at 8510 Colonnade Center Drive, Raleigh, North Carolina 27615 (“Salix”), PROGENICS PHARMACEUTICALS, INC., a Delaware corporation with its principal place of business at 777 Old Saw Mill River Road, Tarrytown, New York 10591 (“Progenics”), and Wyeth LLC, a Delaware limited liability company with its principal place of business at 235 East 42nd Street, New York, New York 10017 (“Wyeth”) (Wyeth, collectively with Valeant, Salix and Progenics, “Plaintiffs”) and PAR STERILE PRODUCTS, LLC (“Par Sterile”), a Delaware limited liability company, with a place of business at 6
CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) THE REGISTRANT CUSTOMARILY AND ACTUALLY TREATS THAT...Confidential Settlement and License Agreement • December 9th, 2022 • Clearone Inc • Telephone & telegraph apparatus • Illinois
This Confidential Settlement and License Agreement ("Agreement") is entered into December 9, 2022, (the "Effective Date") by and between Shure Incorporated, an Illinois corporation having a principal place of business located at 5800 W. Touhy Ave., Niles, Illinois 60714 ("Shure"), and ClearOne, Inc., a Delaware corporation having a principal place of business located at 5225 Wiley Post Way, Suite 500, Salt Lake City, UT 84116 ("ClearOne"). Shure and ClearOne are collectively referred to in this Agreement as the "Parties" and each singly as a "Party."
CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENTConfidential Settlement and License Agreement • June 3rd, 2020 • Alexion Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Portions of this exhibit (indicated by asterisks) have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K. CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENTConfidential Settlement and License Agreement • October 25th, 2023 • Alkermes Plc. • Pharmaceutical preparations • New Jersey
This Confidential Settlement And License Agreement (the “Settlement Agreement”) is hereby entered into on August 29, 2023 (“Execution Date”) by and among
CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENTConfidential Settlement and License Agreement • November 6th, 2015 • Horizon Pharma PLC • Pharmaceutical preparations • New Jersey
This Confidential Settlement And License Agreement (the “Settlement Agreement”) is made effective as of September 9, 2015 (the “Effective Date”) by and among HORIZON PHARMA IRELAND LIMITED, a corporation organized and existing under the laws of Ireland with a principal place of business at Adelaide Chambers, Peter Street, Dublin 8, Ireland (“Horizon Ireland”), HZNP LIMITED, a nonresident Irish company that is a tax resident of Bermuda with a principal place of business at 21 Laffan St., Hamilton, Pembroke, Bermuda HM09 (“HZNP”), and HORIZON PHARMA USA, INC., a corporation organized and existing under the laws of the State of Delaware with a principal place of business at 520 Lake Cook Road, Suite 520, Deerfield, Illinois (“Horizon USA”) (collectively, “Plaintiffs”) and TARO PHARMACEUTICALS USA, INC, a New York corporation with a principal place of business at 3 Skyline Drive, Hawthorne, New York (“Taro USA”) and TARO PHARMACEUTICALS INDUSTRIES, LTD., an Israeli corporation with a princ
CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENTConfidential Settlement and License Agreement • May 31st, 2018 • Progenics Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
This Confidential Settlement And License Agreement (the “Settlement Agreement”) is made effective as of May 25, 2018 (the “Effective Date”) by and among
CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENTConfidential Settlement and License Agreement • November 7th, 2018 • Horizon Pharma PLC • Pharmaceutical preparations • New Jersey
This Confidential Settlement And License Agreement (the “Settlement Agreement”) is entered into by and among HORIZON THERAPEUTICS, LLC, a corporation organized and existing under the laws of the State of Delaware with a principal place of business at 150 S. Saunders Road, Lake Forest, Illinois, 60045 (“Plaintiff”) and PAR PHARMACEUTICAL, INC. (“Par”), a corporation organized and existing under the laws of New York with a principal place of business at One Ram Ridge Road, Chestnut Ridge, NY 10977 (each individually a “Party”, collectively, the “Parties”), and made effective as of the date upon final execution of the Settlement Agreement by an authorized representative of each Party (the “Effective Date”).
CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENTConfidential Settlement and License Agreement • August 7th, 2015 • Horizon Pharma PLC • Pharmaceutical preparations • New Jersey
This Confidential Settlement And License Agreement (the “Settlement Agreement”) is made effective as of May 6th, 2015 (the “Effective Date”) by and among HORIZON PHARMA IRELAND LIMITED, a corporation organized and existing under the laws of Ireland with a principal place of business at Adelaide Chambers, Peter Street, Dublin 8, Ireland (“Horizon Ireland”), HZNP LIMITED, a nonresident Irish company that is a tax resident of Bermuda with a principal place of business at 21 Laffan St., Hamilton, Pembroke, Bermuda HM09 (“HZNP”), and HORIZON PHARMA USA, INC., a corporation organized and existing under the laws of the State of Delaware with a principal place of business at 520 Lake Cook Road, Suite 520, Deerfield, Illinois (“Horizon USA”) (collectively, “Plaintiffs”) and PERRIGO COMPANY, a Michigan corporation with a place of business at 515 Eastern Avenue, Allegan, Michigan 49010 (“Perrigo Co.”) and PADDOCK LABORATORIES, LLC, a limited liability company organized and existing under the laws
